A 48-year-old man presents to the oncology unit with a temperature of 39.2^\circ\text{C} (… — USMLE Step 2 CK

A $48$ -year-old man presents to the oncology unit with a temperature of $39.2^\circ\text{C}$ ( $102.6^\circ\text{F}$ ) and rigors. He is currently on day $10$ of induction chemotherapy for acute myeloid leukemia (AML). Vital signs are pulse $118\text{ /min}$ , blood pressure $95/60\text{ mmHg}$ , and respirations $22\text{ /min}$ . He has an indwelling central venous catheter with no surrounding erythema or purulence. Laboratory studies demonstrate a hemoglobin of $8.5\text{ g/dL}$ , platelets of $45,000/\mu\text{L}$ , and an absolute neutrophil count (ANC) of $100/\mu\text{L}$ .

Arrange the following management steps in the optimal chronological sequence for this patient according to standard oncologic guidelines.

1Draw at least two sets of blood cultures, including one peripheral sample and one from the central venous catheter.
2Administer an empiric intravenous anti-pseudomonal beta-lactam (e.g., cefepime or piperacillin-tazobactam).
3Modify the antimicrobial regimen according to preliminary microbiologic culture and susceptibility data.
4Add an empiric intravenous antifungal agent (e.g., caspofungin) if the patient remains febrile beyond 4 to 7 days.
5Discontinue antimicrobial therapy when the patient has been afebrile for at least 48 hours and the ANC recovers to > 500/μL.

Answer

The correct sequential management of high-risk febrile neutropenia is: 1) Draw blood cultures, 2) Initiate empiric anti-pseudomonal beta-lactams, 3) Tailor therapy based on culture results, 4) Add empiric antifungals if fever persists for 4 to 7 days, and 5) Discontinue therapy upon ANC recovery and defervescence.

The sequence strictly follows the IDSA and ASCO guidelines for managing febrile neutropenia, which is considered a life-threatening oncologic emergency. Securing pathogen samples via blood cultures is the immediate priority to prevent sterilization by antibiotics. However, this must not significantly delay the administration of an anti-pseudomonal beta-lactam, which must occur within 60 minutes of presentation. Once preliminary culture data is obtained, the broad-spectrum regimen is narrowed to optimize efficacy. In high-risk, profoundly neutropenic patients, prolonged fever (beyond 4 to 7 days) despite targeted bacterial coverage strongly suggests an occult invasive fungal infection, prompting the addition of an empiric antifungal agent. Finally, safely discontinuing antimicrobial therapy relies on evidence of functional immune recovery, specifically an absolute neutrophil count exceeding 500/μL accompanied by clinical defervescence.

Step-by-Step Solution

Draw peripheral and central venous blood cultures

Secures diagnostic samples before pathogen eradication

Antibiotics rapidly sterilize the blood; obtaining cultures first ensures accurate identification of the causative organism.

Initiate empiric anti-pseudomonal beta-lactam therapy

Provides immediate broad-spectrum bacterial coverage

Neutropenic patients can rapidly deteriorate from sepsis, particularly from Pseudomonas aeruginosa, requiring administration of antibiotics within 60 minutes of presentation.

Tailor antimicrobial regimen based on culture data

Narrows or adjusts coverage for identified pathogens

Once the pathogen is identified, adjusting the regimen optimizes treatment efficacy and minimizes the risk of developing antimicrobial resistance.

Add empiric antifungal therapy if fever persists > 4 to 7 days

Covers opportunistic fungal pathogens (e.g., Candida, Aspergillus)

Prolonged neutropenic fever despite broad-spectrum antibiotics is a strong clinical indicator of an occult fungal infection.

Discontinue antimicrobial therapy upon recovery

Safely concludes the treatment course

Therapy is stopped once the patient demonstrates clinical stability (afebrile for 48 hours) and functional immune recovery (ANC > 500/μL).

Key Concept

The management of high-risk febrile neutropenia requires immediate blood cultures followed by an anti-pseudomonal beta-lactam, subsequent tailoring based on microbiologic data, addition of empiric antifungals for prolonged fever, and continuation of therapy until neutrophil recovery.

Estimated Time:1m 30s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic